T1	Outcomes 33 71	relapsing-remitting multiple sclerosis
T2	Outcomes 1151 1178	was annualised relapse rate
T3	Outcomes 1496 1523	The annualised relapse rate
T4	Outcomes 1766 1787	patients were relapse
T5	Outcomes 2064 2125	group had serious adverse events excluding multiple sclerosis
T6	Outcomes 2199 2208	a serious
T7	Outcomes 2519 2559	treatment option for relapsing-remitting
